COVID-19: Canada reports first case of blood clots following AstraZeneca shot; Ontario confirms 3,670 new cases

The province completed less than 43,000 tests, marking for a positivity rate of an 8.7 per cent


Top COVID-19 stories and news

Here’s the list of people eligible for vaccines in Phase 2

Here are the rules for Ontario’s new stay-at-home-order

Here’s the list of third wave shutdown restrictions in Ontario

Eight questions answered on the AstraZeneca controversy


Large pop-up vaccination clinic to open in North Etobicoke

3 pm Today, the province announced a large pop-up clinic will open BAPS Shri Swaminarayan Complex in North Etobicoke in partnership with BAPS Charities, William Osler Health System and Toronto Public Health. It will run for three weeks and appointment bookings will be opened through the William Osler Health System booking system to people living nearby on April 14.

The clinic will be open to people age 18 and older in the postal codes M9R, M9V, L4T, and L6S.

Future mobile and pop-up clinics will be promoted locally by community groups and local public health units, and will not use the provincial booking system, the government said today.

The mobile clinics are part of the Ford government’s Phase 2 plan to vaccine everyone 18 and older in 114 hot spot neighbourhoods. The mobile clinics targeting high-transmission areas will rollout first in Toronto and Peel and expand to other regions.

The Ford government also said today it will work with large employers to set up clinics in hot spot areas to vaccinate employees 18 and up, as well as people in neighbouring communities. “This capacity will supplement publicly-run vaccination clinics,” the province said in a statement.

Employers interested in hosting an onsite clinic must meet the following criteria:

  • The workplace must be located within an identified hot-spot community and have had a previous COVID-19 outbreak or is at risk of an outbreak.
  • The onsite clinic will vaccinate employees that cannot work at home, many of whom reside in hot-spot areas.
  • The employer will also vaccinate those in the local community, either at the onsite clinic or an alternative location in consultation with the local public health unit.
  • The employer will take on the responsibility of setting up, operating and funding the onsite vaccination clinic as well as the community clinics being sponsored if not onsite.

First case of blood clots following AstraZeneca vaccine reported in Canada

1:32 pm Public health officials in Ottawa have received the first report of a person living in Canada who has experienced blood clots after receiving a shot of the COVIDSHIELD vaccine – the Serum Institute of India version of the AstraZeneca COVID-19 vaccine.

In a statement, the Public Health Agency of Canada said the person experienced “a very rare adverse event involving blood clots with low platelets.”

The person is now at home recovering, the agency added.

“Reports of blood clots with low platelets in people vaccinated with the AstraZeneca COVID-19 vaccine are very rare and the report of this case shows that Canada’s vaccine safety monitoring system works,” the statement continued. “Since these rare adverse events were first reported in early March 2021 in Europe, Health Canada has been working with international regulators to review data and evidence as it becomes available.”

Last month, Canada’s National Advisory Committee on Immunization recommended to the provinces that the use of AstraZeneca vaccines be limited to people age 55 following very rare instances of blood clots in immunized patients – primarily young women.

As the COVID-19 vaccine rollout advances in Canada, Health Canada and the Public Health Agency of Canada will continue to monitor the use of all COVID-19 vaccines closely and examine and assess any new safety concerns,” Health Canada said in a statement. “Based on all of the evidence available internationally to-date, Health Canada continues to consider that the benefits of the AstraZeneca and COVISHIELD vaccines to protect against COVID-19 outweigh the potential risks.”


Health Canada issues statement on Johnson & Johnson vaccine

12:17 pm After federal regulators in the United States recommended a “pause” in use of the the single-dose Johnson & Johnson COVID-19 vaccine, Health Canada has issued a statement saying agency is following developments “closely.”

On Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration said in a joint statement that officials were investigating six cases of “rare and severe” blood clots that occurred in women between 18 and 48 six-to-13 days after they had received the Janssen-made vaccine.

“HC is following this issue closely and is working with the manufacturer, the US Food and Drug Administration and other international regulators,” the federal agency said in a tweet. “Health Canada has asked Janssen to provide information on any cases of these rare blood clotting events.”

Health Canada approved the vaccine for usage on March 5, but no shipments have arrived. As of April 12, more than 6.8 million doses of the Johnson & Johnson vaccine had been administered in the United States.


Ontario reports more than 3,600 new COVID-19 cases

11 am Ontario reported 3,670 new COVID-19 cases and 15 more deaths on April 13.

The province detected 4,401 new cases on Monday, 4,456 on Sunday and 3,813 on Saturday. Despite a drop in cases Tuesday compared to the past few days, the seven-day rolling average continues to increase, reaching 3,868 today.

The lower daily case count can also be attributed to low testing numbers – the province completed just 42,167 tests in the past 24 hours, marking an 8.7 per cent positivity rate. The province is also reporting a testing backlog of over 35,000.

Ontario administered 95,692 doses in the past day, bringing the provincial total to 3,310,157 doses and 335,262 people fully vaccinated.

There are 35,840 active cases across the province, well above the active case count of the peak of the second wave, which hovered around 30,000. Hospitalizations have jumped from 1,646 to 1,822, including 626 people in intensive care with 422 on ventilators.

Of the 15 deaths reported today, one was between the ages of 20 and 39.

Variants of concern are growing at a staggering rate, with 3,947 confirmed B117 cases reported today compared to just over 2,000 the day before. Three more P1 cases have been confirmed as well.

To date, the province has seen 394,679 total COVID-19 cases, along with 7,582 deaths.


New COVID-19 cases in Ontario on April 13

The following regions reported five or more new COVID-19 cases:

Toronto = 1,016

Peel = 613

York Region = 519

Ottawa = 214

Durham Region = 196

City of Hamilton = 161

Halton Region = 157

Region of Waterloo = 121

Niagara Region = 103

Simcoe Muskoka District = 102

Middlesex-London = 83

Wellington-Dufferin-Guelph = 78

Sudbury & Districts = 44

Windsor-Essex County = 42

Eastern Ontario = 32

Southwestern = 30

Brant County = 27

Leeds, Grenville & Lanark District = 19

Hastings Prince Edward = 16

Renfrew County and District = 15

Northwestern = 13

Grey Bruce = 12

Haliburton, Kawartha, Pine Ridge = 8

Peterborough = 7

Chatham-Kent = 7

Haldimand-Norfolk = 6

Thunder Bay District = 5

Algoma = 5

North Bay Parry Sound District = 5

Porcupine = 5

Lambton = 5

@nowtoronto

Leave your opinion for the editor...We read everything!

Your email address will not be published. Required fields are marked *

  • This Week’s Issue